Narya Bio
Narya Bio is developing novel therapeutic antibodies for challenging diseases.
About
Narya Bio is a biotechnology company focused on developing next-generation therapeutic antibodies. They leverage advanced computational and biological approaches to design antibodies with improved efficacy and safety profiles for diseases that are currently difficult to treat.
Technology stack
detected 2026-05-24CDN
Cloudflare
Email
Google Workspace
Performance
Company Timeline
Capital network
Open in Market Map editorFrequently asked
What does Narya Bio do?
Narya Bio is a biotechnology company focused on developing next-generation therapeutic antibodies. They leverage advanced computational and biological approaches to design antibodies with improved efficacy and safety profiles for diseases that are currently difficult to treat.
How much funding has Narya Bio raised?
Narya Bio has raised a total of $55M in funding. The most recent round on record is Series A.
Where is Narya Bio headquartered?
Narya Bio is headquartered in רחובות, Israel.
When was Narya Bio founded?
Narya Bio was founded in 2026.
What industry does Narya Bio operate in?
Narya Bio operates in Biotech, Drug Discovery, Antibody Therapeutics, Genomics, AI-Driven Protein Design.
How many employees does Narya Bio have?
Narya Bio has approximately 8 people on record.